Similar structures but different roles-an updated perspective on TLR structures

Frontiers in Physiology

Volumn JUL, Issue , 2011, Pages 1-13

  Manavalan, Balachandran ^a   Basith, Shaherin ^a   Choi, Sangdun ^a  

^a Ajou University   (South Korea)

Author keywords

Innate immunity; ligand; myeloid differentiation factor 88; toll like receptor

Indexed keywords

EID: 80052285936     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2011.00041     Document Type: Article

References (78)

1. Alexopoulou, L., Holt, A. C., Medzhitov, R., and Flavell, R. A. (2001). Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413, 732-738.
2. Andersen-Nissen, E., Smith, K. D., Bonneau, R., Strong, R. K., and Aderem, A. (2007). A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin. J. Exp. Med. 204, 393-403.
3. Basith, S., Manavalan, B., Govindaraj, R. G., and Choi, S. (2011a). In silico approach to inhibition of signaling pathways of toll-like receptors 2 and 4 by ST2L. PLoS ONE (in press).
4. Basith, S., Manavalan, B., Lee, G., Kim, S. G., and Choi, S. (2011b). Tolllike receptor modulators: a patent review (2006-2010). Expert. Opin. Ther. Pat. 21, 927-944.
5. Bell, J. K., Askins, J., Hall, P. R., Davies, D. R., and Segal, D. M. (2006). The dsRNA binding site of human Tolllike receptor 3. Proc. Natl. Acad. Sci. U.S.A. 103, 8792-8797.
6. Bell, J. K., Botos, I., Hall, P. R., Ask-ins, J., Shiloach, J., Segal, D. M., and Davies, D. R. (2005). The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc. Natl. Acad. Sci. U.S.A. 102, 10976-10980.
7. Bell, J. K., Mullen, G. E., Leifer, C. A., Mazzoni,A., Davies, D. R., and Segal, D. M. (2003). Leucine-rich repeats and pathogen recognition in Tolllike receptors. Trends Immunol. 24, 528-533.
8. Botos, I., Segal, D. M., and Davies, D. R. (2011). The structural biology of Toll-like receptors. Structure 19, 447-459.
9. Brodsky, I., and Medzhitov, R. (2007). Two modes of ligand recognition by TLRs. Cell 130, 979-981.
10. Bryant, C. E., Spring, D. R., Gangloff, M., and Gay, N. J. (2010). The molecular basis of the host response to lipopolysaccharide. Nat. Rev. Microbiol. 8, 8-14.
11. Buchanan, S. G., and Gay, N. J. (1996). Structural and functional diversity in the leucine-rich repeat family of proteins. Prog. Biophys. Mol. Biol. 65, 1-44.
12. Carpenter, S., and O'Neill, L. A. (2009). Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. Biochem. J. 422, 1-10.
13. Chan, S. L., Low, L. Y., Hsu, S., Li, S., Liu, T., Santelli, E., Le Negrate, G., Reed, J. C., Woods, V. L. Jr., and Pascual, J. (2009). Molecular mimicry in innate immunity: crystal structure of a bacterial TIR domain. J. Biol. Chem. 284, 21386-21392.
14. Chan, S. L., Mukasa, T., Santelli, E., Low, L. Y., and Pascual, J. (2010). The crystal structure of a TIR domain from Arabidopsis thaliana reveals a conserved helical region unique to plants. Protein Sci. 19, 155-161.
15. Choe, J., Kelker, M. S., and Wilson, I. A. (2005). Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain. Science 309, 581-585.
16. Dolan, J., Walshe, K., Alsbury, S., Hokamp, K., O'Keeffe, S., Okafuji, T., Miller, S. F., Tear, G., and Mitchell, K. J. (2007). The extracellular leucine-rich repeat superfamily; a comparative survey and analysis of evolutionary relationships and expression patterns. BMC Genomics. 8, 320. doi: 10.1186/1471-2164-10-230
17. Fukuda, K., Watanabe, T., Tokisue, T., Tsujita, T., Nishikawa, S., Hasegawa, T., Seya, T., and Matsumoto, M. (2008). Modulation of double-stranded RNA recognition by the N-terminal histidine-rich region of the human Toll-like receptor 3. J. Biol. Chem. 283, 22787-22794.
18. Gay, N. J., and Gangloff, M. (2007). Structure and function of Toll receptors and their ligands. Annu. Rev. Biochem. 76, 141-165.
19. Gay, N. J., Gangloff, M., and O'Neill, L. A. (2011). What the myddosome structure tells us about the initiation of innate immunity. Trends Immunol. 32, 104-109.
20. George, J., Motshwene, P. G., Wang, H., Kubarenko, A. V., Rautanen, A., Mills, T. C., Hill, A. V., Gay, N. J., and Weber, A. N. (2011). Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly. J. Biol. Chem. 286, 1341-1353.
21. Gong, J., Wei, T., Stark, R. W., Jamitzky, F., Heckl, W. M., Anders, H. J., Lech, M., and Rossle, S. C. (2010). Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR: a computational approach. J. Struct. Biol. 169, 323-330.
22. Gong, J., Wei, T., Zhang, N., Jamitzky, F., Heckl,W. M., Rossle, S. C., and Stark, R. W. (2011). TollML: a database of Toll-like receptor structural motifs. J. Mol. Model. 16, 1283-1289.
23. Govindaraj, R. G., Manavalan, B., Lee, G., and Choi, S. (2010). Molecular modeling-based evaluation of hTLR10 and identification of potential ligands in Toll-like receptor signaling. PLoS ONE 5, e12713. doi: 10.1371/journal.pone.0012713
24. Grabiec, A., Meng, G., Fichte, S., Bessler, W., Wagner, H., and Kirschning, C. J. (2004). Human but not murine Toll-like receptor 2 discriminates between tri-palmitoylated and tri-lauroylated peptides. J. Biol. Chem. 279, 48004-48012.
25. Guan, Y., Ranoa, D. R., Jiang, S., Mutha, S. K., Li, X., Baudry, J., and Tapping, R. I. (2010). Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling. J. Immunol. 184, 5094-5103.
26. Hantke, K., and Braun, V. (1973). Covalent binding of lipid to protein. Diglyceride and amide-linked fatty acid at the N-terminal end of the murein-lipoprotein of the Escherichia coli outer membrane. Eur. J .Biochem. 34, 284-296.
27. Henriques, E. S., Brito, R. M., Soares, H., Ventura, S., De Oliveira, V. L., and Parkhouse, R. M. (2011). Modeling of the Toll-like receptor 3 and a putative Toll-like receptor 3 antagonist encoded by the African swine fever virus. Protein Sci. 20, 247-255.
28. Jin, M. S., Kim, S. E., Heo, J. Y., Lee, M. E., Kim, H. M., Paik, S. G., Lee, H., and Lee, J. O. (2007). Crystal structure of the TLR1-TLR2 het-erodimer induced by binding of a tri-acylated lipopeptide. Cell 130, 1071-1082.
29. Jin, M. S., and Lee, J. O. (2008). Structures of the Toll-like receptor family and its ligand complexes. Immunity 29, 182-191.
30. Kagan, J. C., Su, T., Horng, T., Chow, A., Akira, S., and Medzhitov, R. (2008). TRAM couples endocytosis of Tolllike receptor 4 to the induction of interferon-beta. Nat. Immunol. 9, 361-368.
31. Kajava, A. V., Vassart, G., and Wodak, S. J. (1995). Modeling of the three-dimensional structure of proteins with the typical leucine-rich repeats. Structure 3, 867-877.
32. Kang, J. Y., and Lee, J. O. (2011). Structural biology of the Toll-like receptor family. Annu. Rev. Biochem. 80, 917-941.
33. Kang, J. Y., Nan, X., Jin, M. S., Youn, S. J., Ryu, Y. H., Mah, S., Han, S. H., Lee, H., Paik, S. G., and Lee, J. O. (2009). Recognition of lipopep-tide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 31, 873-884.
34. Kariko, K., Bhuyan, P., Capodici, J., and Weissman, D. (2004). Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through Toll-like receptor 3. J. Immunol. 172, 6545-6549.
35. Kawai, T., and Akira, S. (2010). The role of pattern-recognition receptors in innate immunity: update on Tolllike receptors. Nat. Immunol. 11, 373-384.
36. Khan, J. A., Brint, E. K., O'Neill, L. A., and Tong, L. (2004). Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL. J. Biol. Chem. 279, 31664-31670.
37. Kim, H. M., Oh, S. C., Lim, K. J., Kasamatsu, J., Heo, J. Y., Park, B. S., Lee, H., Yoo, O. J., Kasahara, M., and Lee, J. O. (2007a). Structural diversity of the hagfish variable lymphocyte receptors. J. Biol. Chem. 282, 6726-6732.
38. Kim, H. M., Park, B. S., Kim, J. I., Kim, S. E., Lee, J., Oh, S. C., Enkhbayar, P., Matsushima, N., Lee, H., Yoo, O. J., and Lee, J. O. (2007b). Crystal structure of the TLR4-MD-2 complex with bound endo-toxin antagonist Eritoran. Cell. 130, 906-917.
39. Kleinman, M. E., Yamada, K., Takeda, A., Chandrasekaran, V., Nozaki, M., Baffi, J. Z., Albuquerque, R. J., Yamasaki, S., Itaya, M., Pan, Y., Appukuttan, B., Gibbs, D., Yang, Z., Kariko, K., Ambati, B. K., Wilgus, T. A., Dipietro, L. A., Sakurai, E., Zhang, K., Smith, J. R., Taylor, E. W.,and Ambati,J. (2008). Sequence-and target-independent angiogene-sis suppression by siRNA via TLR3. Nature 452, 591-597.
40. Kobayashi, M., Saitoh, S., Tanimura, N., Takahashi, K., Kawasaki, K., Nishijima, M., Fujimoto, Y., Fukase, K., Akashi-Takamura, S., and Miyake, K. (2006). Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering. J. Immunol. 176, 6211-6218.
41. Kobe, B., and Deisenhofer, J. (1995). A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature 374, 183-186.
42. Kobe, B., and Kajava, A. V. (2001). The leucine-rich repeat as a protein recognition motif. Curr. Opin. Struct. Biol. 11, 725-732.
43. Kubarenko, A., Frank, M., and Weber, A. N. (2007). Structure-function relationships of Toll-like receptor domains through homology modelling and molecular dynamics. Biochem. Soc. Trans. 35, 1515-1518.
44. Kubarenko, A. V., Ranjan, S., Colak, E., George, J., Frank, M., and Weber, A. N. (2010). Comprehensive modeling and functional analysis of Toll-like receptor ligand-recognition domains. Protein Sci. 19, 558-569.
45. Latz, E., Verma, A., Visintin, A., Gong, M., Sirois, C. M., Klein, D. C., Monks, B. G., Mcknight, C. J., Lamphier, M. S., Duprex, W. P., Espevik, T., and Golenbock, D. T. (2007). Ligand-induced conforma-tional changes allosterically activate Toll-like receptor 9. Nat. Immunol. 8, 772-779.
46. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J. M., and Hoffmann, J. A. (1996). The dorsoventral regulatory gene cassette spat-zle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973-983.
47. Leonard, J. N., Ghirlando, R., Askins, J., Bell, J. K., Margulies, D. H., Davies, D. R., and Segal, D. M. (2008). The TLR3 signaling complex forms by cooperative receptor dimerization. Proc. Natl. Acad. Sci. U.S.A. 105, 258-263.
48. Liang, S., Hosur, K. B., Lu, S., Nawar, H. F., Weber, B. R., Tapping, R. I., Connell, T. D., and Hajishengallis, G. (2009). Mapping of a microbial protein domain involved in binding and activation of the TLR2/TLR1 heterodimer. J. Immunol. 182, 2978-2985.
49. Lin, S. C., Lo, Y. C., and Wu, H. (2010). Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature. 465, 885-890.
50. Liu, L., Botos, I., Wang, Y., Leonard, J. N., Shiloach, J., Segal, D. M., and Davies, D. R. (2008). Structural basis of Toll-like receptor 3 signaling with double-stranded RNA. Science. 320, 379-381.
51. Manavalan, B., Basith, S., Choi, Y. M., Lee, G., and Choi, S. (2010). Structure-function relationship of cytoplasmic and nuclear IkappaB proteins: an in silico analysis. PLoS ONE 5, e15782. doi: 10.1371/jour-nal.pone.0015782
52. Manavalan, B., Govindaraj, R., Lee, G., and Choi, S. (2011). Molecular modeling-based evaluation of dual function of IkappaBzeta ankyrin repeat domain in Toll-like receptor signaling. J. Mol. Recognit. 24, 597-607.
53. Matsushima, N., Tanaka, T., Enkhbayar, P., Mikami, T., Taga, M., Yamada, K., and Kuroki,Y. (2007). Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate Toll-like receptors. BMC Genomics 8, 124. doi: 10.1186/1471-2164-8-124
54. Means, T. K., Golenbock, D. T., and Fenton, M. J. (2000). The biology of Toll-like receptors. Cytokine Growth Factor Rev. 11, 219-232.
55. Muhlradt, P. F., Kiess, M., Meyer, H., Sussmuth, R., and Jung, G. (1997). Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 185, 1951-1958.
56. Mullarkey, M., Rose, J. R., Bristol, J., Kawata, T., Kimura, A., Kobayashi, S., Przetak, M., Chow, J., Gusovsky, F., Christ, W. J., and Rossignol, D. P. (2003). Inhibition of endotoxin response by e5564, a novel Tolllike receptor 4-directed endotoxin antagonist. J. Pharmacol. Exp. Ther. 304, 1093-1102.
57. Nunez Miguel, R., Wong, J., Westoll, J. F., Brooks, H. J., O'Neill, L. A., Gay, N. J., Bryant, C. E., and Monie, T. P. (2007). A dimer of the Tolllike receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins. PLoS ONE 2, e788. doi: 10.1371/journal.pone.0000788
58. Nyman, T., Stenmark, P., Flodin, S., Johansson, I., Hammarstrom, M., and Nordlund, P. (2008). The crystal structure of the human Toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer. J. Biol. Chem. 283, 11861-11865.
59. Ohnishi, H., Tochio, H., Kato, Z., Orii, K. E., Li, A., Kimura, T., Hiroaki, H., Kondo, N., and Shirakawa, M. (2009). Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling. Proc. Natl. Acad. Sci. U.S.A. 106, 10260-10265.
60. Ohto, U., Fukase, K., Miyake, K., and Satow, Y. (2007). Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science. 316, 1632-1634.
61. Omueti, K. O., Mazur, D. J., Thompson, K. S., Lyle, E. A., and Tapping, R. I. (2007). The polymorphism P315L of human Toll-like receptor 1 impairs innate immune sensing of microbial cell wall components. J. Immunol. 178, 6387-6394.
62. Palsson-Mcdermott, E. M., and O'Neill, L. A. (2007). Building an immune system from nine domains. Biochem. Soc. Trans. 35, 1437-1444.
63. Park, B. S., Song, D. H., Kim, H. M., Choi, B. S., Lee, H., and Lee, J. O. (2009). The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature. 458, 1191-1195.
64. Ranjith-Kumar, C. T., Miller, W., Xiong, J., Russell, W. K., Lamb, R., Santos, J., Duffy, K. E., Cleveland, L., Park, M., Bhardwaj, K., Wu, Z., Russell, D. H., Sarisky, R. T., Mbow, M. L., and Kao, C. C. (2007). Biochemical and functional analyses of the human Tolllike receptor 3 ectodomain. J. Biol. Chem. 282, 7668-7678.
65. Resman, N., Vasl, J., Oblak, A., Pristovsek, P., Gioannini, T. L., Weiss, J. P., and Jerala, R. (2009). Essential roles of hydrophobic residues in both MD-2 and Tolllike receptor 4 in activation by endotoxin. J. Biol. Chem. 284, 15052-15060.
66. Rosetto, M., Engstrom, Y., Baldari, C. T., Telford, J. L., and Hultmark, D. (1995). Signals from the IL-1 receptor homolog, Toll, can activate an immune response in a Drosophila hemocyte cell line. Biochem. Biophys. Res. Commun. 209, 111-116.
67. Rossignol, D. P., and Lynn, M. (2005). TLR4 antagonists for endotoxemia and beyond. Curr. Opin. Investig. Drugs 6, 496-502.
68. Shibata, K., Hasebe, A., Into, T., Yamada, M., and Watanabe, T. (2000). The N-terminal lipopeptide of a 44-kDa membrane-bound lipoprotein of Mycoplasma salivarium is responsible for the expression of intercellular adhesion molecule-1 on the cell surface of normal human gingival fibroblasts. J. Immunol. 165, 6538-6544.
69. Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., and Kimoto, M. (1999). MD-2, a molecule that confers lipopolysac-charide responsiveness on Tolllike receptor 4. J. Exp. Med. 189, 1777-1782.
70. Tao, X., Xu, Y., Zheng, Y., Beg, A. A., and Tong, L. (2002). An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2.Biochem. Biophys. Res. Commun. 299, 216-221.
71. Walsh, C., Gangloff, M., Monie, T., Smyth, T., Wei, B., Mckinley, T. J., Maskell, D., Gay, N., and Bryant, C. (2008). Elucidation of the MD-2/TLR4 interface required for signal ing by lipid IVa. J. Immunol. 181, 1245-1254.
72. Wang,Y., Liu, L., Davies, D. R., and Segal, D. M. (2010). Dimerization of Toll like receptor 3 (TLR3) is required for ligand binding. J. Biol. Chem. 285, 36836-36841.
73. Wei, T., Gong, J., Jamitzky, F., Heckl, W. M., Stark, R. W., and Rossle, S. C. (2008). LRRML: a conformational database and an XML description of leucine-rich repeats (LRRs). BMC. Struct. Biol. 8, 47. doi: 10.1186/1472-6807-8-47
74. Wei, T., Gong, J., Jamitzky, F., Heckl, W. M., Stark, R. W., and Rossle, S. C. (2009). Homology modeling of human Toll-like receptors TLR7, 8, and 9 ligand-binding domains. Protein Sci. 18, 1684-1691.
75. Wei, T., Gong, J., Rossle, S. C., Jamitzky, F., Heckl, W. M., and Stark, R. W. (2010). A leucine-rich repeat assembly approach for homology modeling of the human TLR5-10 and mouse TLR11-13 ectodomains. J. Mol. Model. 17, 27-36.
76. Xu, Y., Tao, X., Shen, B., Horng, T., Medzhitov, R., Manley, J. L., and Tong, L. (2000). Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature. 408, 111-115.
77. Zahringer, U., Lindner, B., Inamura, S., Heine, H., and Alexander, C. (2008). TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213, 205-224.
78. Zhu, J., Brownlie, R., Liu, Q., Babiuk, L. A., Potter, A., and Mutwiri, G. K. (2009). Characterization of bovine Toll-like receptor 8: ligand specificity, signaling essential sites and dimerization. Mol. Immunol. 46, 978-990.